Complexa, Inc.

Complexa researches and develops highly selective nitrated fatty-acids (NFAs) cell signaling agents that modulate the key inflammatory and fibrosis pathways. Our compound library focuses on Enhancing tissue protection & repair (mediating their effect through the modulation of Nrf2 and Heat Shock Response) and Inhibition of inflammation events (mediating their effects through blockade of NF-kB and Xanthine Oxido-Reductase).